80年代土耳其译制电影,80年代外国电影|80年代外国电影有哪些_80年代外国经典电影在线播放地址是多少？

[1]伍麗娟,倪許玲,陳心蓓,等.甘油三酯-葡萄糖指數(shù)聯(lián)合內(nèi)臟脂肪面積檢測對糖尿病前期和糖尿病的預測價值[J].福建醫(yī)藥雜志,2025,47(03):5-11.[doi:10.20148/j.fmj.2025.03.002]
　WU Lijuan,NI Xuling,CHEN Xinbei,et al.Predictive value of detection of triglyceride-glucose index combined with visceral fat area in prediabetes and diabetes[J].FUJIAN MEDICAL JOURNAL,2025,47(03):5-11.[doi:10.20148/j.fmj.2025.03.002]
點擊復制

甘油三酯-葡萄糖指數(shù)聯(lián)合內(nèi)臟脂肪面積檢測對糖尿病前期和糖尿病的預測價值()
分享到：

《福建醫(yī)藥雜志》[ISSN:1002-2600/CN:35-1071/R]

卷:
47
期數(shù):
2025年03期
頁碼:
5-11
欄目:
臨床研究
出版日期:
2025-03-20

文章信息/Info

Title:
Predictive value of detection of triglyceride-glucose index combined with visceral fat area in prediabetes and diabetes
文章編號:
1002-2600(2025)03-0005-07
作者:
伍麗娟1; 倪許玲1; 陳心蓓1; 葉金連1; 尹蓮花1; 2
1 福建中醫(yī)藥大學附屬第二人民醫(yī)院,福州 350003; 2 福建中醫(yī)藥大學康復技術省部共建協(xié)同創(chuàng)新中心,福州 350108
Author(s):
WU Lijuan1;  NI Xuling1;  CHEN Xinbei1;  YE Jinlian1;  YIN Lianhua1; 2
1 The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350003, China; 2 Rehabilitation technology innovation center by joint collaboration of education and Fujian Province, Fujian University of traditional Chinese Medicine, Fuzhou, Fujian 350108, China
關鍵詞:
糖尿病前期;  糖尿病;  甘油三酯-葡萄糖指數(shù);  內(nèi)臟脂肪面積
Keywords:
prediabetes;  diabetes;  triglyceride-glucose index;  visceral fat area
分類號:
R587.1
DOI:
10.20148/j.fmj.2025.03.002
文獻標志碼:
B
摘要:
目的 探討甘油三酯-葡萄糖指數(shù)(TyG)、低密度脂蛋白膽固醇與高密度脂蛋白膽固醇的比值(LDL-C/HDL-C)及內(nèi)臟脂肪面積(VFA)檢測對糖尿病前期和糖尿病的預測價值。方法 回顧性分析于福建中醫(yī)藥大學附屬第二人民醫(yī)院健康管理中心(治未病)體檢的255名受試者,按糖尿病前期和糖尿病診斷標準分為糖尿病前期組(n=100)、糖尿病組(n=79)、血糖正常組(n=76)。兩兩比較3組人群的理化指標,主要包括TG、TC、LDL-C、HDL-C、TyG、LDL-C/HDL-C、體重、BMI、脂肪量、肌肉量、體脂肪量(BF)、蛋白質(zhì)、VFA、皮下脂肪含量(SFC)等,采用多因素 logistic 回歸分析糖尿病前期和糖尿病的影響因素,使用受試者工作特征(ROC)曲線評估TyG、VFA以及TyG聯(lián)合VFA對糖尿病前期和糖尿病的預測價值。結果 糖尿病前期組和糖尿病組的TG、LDL-C、TyG、LDL-C/HDL-C均高于血糖正常組,HDL-C低于血糖正常組; 糖尿病組的TyG高于糖尿病前期組,HDL-C低于糖尿病前期組(均P<0.05)。糖尿病前期組的體重、BMI、脂肪量、身體水分、BF、VFA、VFC、SFC高于血糖正常組; 糖尿病組的體重、BMI、脂肪量、BF、VFA、VFC、浮腫指數(shù)均高于血糖正常組(均P<0.05)。TyG、VFA是糖尿病前期和糖尿病的影響因素(P<0.05),LDL-C/HDL-C不是糖尿病前期和糖尿病的影響因素(P>0.05)。對于糖尿病前期,TyG的AUC為0.719,最佳切點為7.225,VFA的AUC為0.667,最佳切點為53.5,TyG+VFA的AUC為0.743; 對于糖尿病,TyG的AUC為0.817,最佳切點為7.218,VFA的AUC為0.683,最佳切點61.75,TyG+VFA的AUC為0.822。結論 TyG、VFA是糖尿病前期和糖尿病的影響因素,兩者聯(lián)合檢測對糖尿病前期和糖尿病具有更優(yōu)的預測價值。
Abstract:
Objective To explore the predictive value of the triglyceride-glucose index(TyG), the ratio of low-density lipoprotein cholesterol to high-density lipoprotein cholesterol(LDL-C/HDL-C), and visceral fat area(VFA)for prediabetes and diabetes. Methods A retrospective analysis was conducted on 255 subjects who underwent physical examination at the Health Management Center(Treat Before Illness)of the Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine. They were divided into prediabetes group(n=100), diabetes group(n=79), and normal glucose group(n=76),according to the diagnostic criteria for prediabetes and diabetes. The physical and chemical indicators of the three groups were compared, including TG, TC, LDL-C, HDL-C, TyG, LDL-C/HDL-C, weight, BMI, fat mass, muscle mass, BF, protein, VFA, SFC, etc. Multiple factor logistic regression analysis was used to analyze the influencing factors of prediabetes and diabetes, and the receiver operating characteristic(ROC)curve was used to evaluate the predictive value of TyG, VFA, and the combination of TyG and VFA for prediabetes and diabetes. Results The levels of TG, LDL-C, TyG, and LDL-C/HDL-C in the prediabetes group and diabetes group were higher than those in the normal glucose group, while HDL-C was lower than that in the normal glucose group(P<0.05). The TyG in the diabetes group was higher than that in the prediabetes group, and HDL-C was lower than that in the prediabetes group(P<0.05). The weight, BMI, fat mass, body water, BF, VFA, VFC, and SFC in the prediabetes group were higher than those in the normal glucose group; the weight, BMI, fat mass, BF, VFA, VFC, and edema index in the diabetes group were higher than those in the normal glucose group(all P<0.05). TyG and VFA were influence factors for prediabetes and diabetes(P<0.05), LDL-C and HDL-C were not influence factors for prediabetes and diabetes(P>0.05). For prediabetes, the AUC of TyG was 0.719, the optimal cut-off was 7.225, the AUC of VFA was 0.667, the optimal cut-off was 53.5, and the AUC of TyG and VFA was 0.743; for diabetes, the AUC of TyG was 0.817, the optimal cut-off was 7.218, the AUC of VFA was 0.683, the optimal cut-off was 61.75, and the AUC of TyG and VFA was 0.822. Conclusion TyG and VFA are influence factors for prediabetes and diabetes, and the combined detection has better predictive value for prediabetes and diabetes.

參考文獻/References:

[1] Sun H,Saeedi P,Karuranga S,et al.IDF Diabetes atlas:global,regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J].Diabetes Res Clin Pract,2022(183):109119.
[2] Nathan D M,Davidson M B,DeFronzo R A,et al.Impaired fasting glucose and impaired glucose tolerance:implications for care[J].Diabetes Care,2007,30(3):753-759.
[3] 中國2型糖尿病防治指南(2020年版)(上)[J].中國實用內(nèi)科雜志,2021,41(8):668-695.
[4] 中華醫(yī)學會內(nèi)分泌學分會,中華醫(yī)學會糖尿病學分會,中國醫(yī)師協(xié)會內(nèi)分泌代謝科醫(yī)師分會,等.中國成人糖尿病前期干預的專家共識(2023版)[J].中華糖尿病雜志,2023,15(6):484-494.
[5] Kawamoto R,Tabara Y,Kohara K,et al.Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults[J].Lipids Health Dis,2010,9:138.
[6] Han T S,Al-Gindan Y Y,Govan L,et al.Associations of BMI,waist circumference,body fat,and skeletal muscle with type 2 diabetes in adults[J].Acta Diabetol,2019(56):947-954.
[7] Kurioka S,Murakami Y,Nishiki M,et al.Relationship between visceral fat accumulation and anti-lipolytic action of insulin in patients with type 2 diabetes mellitus[J].Endocr J,2002(49):459-464.
[8] Mutie P M,Pomares M H,Atabaki P N,et al.An investigation of causal relationships between prediabetes and vascular complications[J].Nat Commun,2020,11:4592.
[9] Paneni F,Costantino S,Cosentino F.Insulin resistance,diabetes,and cardiovascular risk[J].Curr Atheroscler Rep,2014,16(7):419.
[10] 肖揚,于碧蓮.糖尿病患者血脂管理中國專家共識(2024版)[J].中國循環(huán)雜志,2024,39(4):322-341.
[11] 李蓉蓉,張永紅,李莉,等.內(nèi)臟脂肪區(qū)域、體脂肪率及血脂異常與糖尿病前期的關系[J].實用預防醫(yī)學,2019,26(2):146-149.
[12] Rajput R,Garg R,Rajput M,et al.Body composition and handgrip strength in patients with prediabetes:a case-control study from Haryana,North India.Diabetes Metab Syndr[J].2021,15(3):823-827.
[13] 賀娟,王穎,尤春娟,等.新診斷2型糖尿病患者體脂肪變化及相關影響因素分析[J].寧夏醫(yī)學雜志,2024,46(6):519-521.
[14] Fernando G R,Luis E,Manuel G O,et al.The product of triglycerides and glucose,a simple measure of insulin sensitivity comparison with the euglycemic-hyperinsulinemic clamp[J].J Clin Endocrinol Metab,2010,95(7):3347-3351.
[15] Darshan A V,Rajput R,Saini S.Comparison of triglyceride glucose index and HbA1C as a marker of prediabetes-a preliminary study[J].Diabetes Metab Syndr,2022,16(9):102605.
[16] Lee J W,Lim N K,Park H Y.The product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans[J].BMC Endocr Disord,2018,18:33.
[17] Zi Q,Wang L M,Zhao S.Triglyceride-glucose index as predictor for future type 2 diabetes mellitus in a Chinese population in southwest China:a 15-year prospective study[J].Endocrine,2021(72):124-131.
[18] Park B,Lee H S,Lee Y J.Triglyceride glucose(TyG)index as a predictor of incident type 2 diabetes among nonobese adults:a 12-year longitudinal study of the Korean genome and epidemiology study cohort[J].Transl Res,2021(228):42-51.
[19] Wen J,Wang A,Liu G,et al.Elevated triglyceride-glucose(TyG)index predicts incidence of prediabetes:a prospective cohort study in China[J].Lipids Health Dis,2020,19(1):226.
[20] Zhou Y M,Yang G P,Chen Q,et al.Predictive performance of lipid parameters in identifying undiagnosed diabetes and prediabetes:a cross-sectional study in eastern China[J].BMC Endocr Disord,2022,22:76.
[21] Kumpatla S,Parveen R,Murugan P,et al.Hyperglucagone-mia and impaired insulin sensitivity are associated with development of prediabetes and type 2 diabetes - a study from South India[J].Diabetes Metab Syndr,2021,15(4):102199.
[22] Zhang L H,Zeng L.Non-linear association of triglyceride-glucose index with prevalence of prediabetes and diabetes:a cross-sectional study[J].Front Endocrinol(Lausanne),2023,14:1-10.
[23] 吳延莉,蘇旭,王藝穎,等.LDL-C/HDL-C比值與2型糖尿病發(fā)病關系的隊列研究[J].現(xiàn)代預防醫(yī)學,2023,50(12):2252-2258.
[24] 余國慶,孫紅,李君,等.2型糖尿病患者TyG指數(shù)、LDL-C/HDL-C比值與糖化血紅蛋白的相關性研究[J].糖尿病新世界,2023,26(9):18-22.
[25] 計葉,徐文超.血脂參數(shù)及脂質(zhì)比值與糖代謝異常的關聯(lián)研究[J].現(xiàn)代預防醫(yī)學,2024,51(14):2628-2633.
[26] 中華醫(yī)學會內(nèi)分泌學分會,中華中醫(yī)藥學會糖尿病分會,中國醫(yī)師協(xié)會外科醫(yī)師分會肥胖和糖尿病外科醫(yī)師委員會,中國研究型醫(yī)院學會糖尿病與肥胖外科專業(yè)委員會.基于臨床的肥胖癥多學科診療共識(2021年版)[J].中華消化外科雜志,2021,20(11):1137-1152.
[27] 中華醫(yī)學會內(nèi)分泌學分會.中國2型糖尿病合并肥胖綜合管理專家共識 [J].中華糖尿病雜志,2016,8(11):662-666.
[28] 劉惠雙.腹腔內(nèi)臟脂肪面積與慢性疾病相關性研究[J].中國現(xiàn)代藥物應用,2016,10(2):88-89.
[29] Rubio-Almanza M,Cámara-Gómez R,Merino-Torres J F.Obesity and type 2 diabetes:also linked in therapeutic options[J].Endocrinol Diabetes Nutr(Engl Ed),2019,66(3):140-149.
[30] 盧新妍,林萱,崔靜,等.甘油三酯-葡萄糖指數(shù)與內(nèi)臟脂肪面積聯(lián)合檢測對2型糖尿病早期外周血管病變的預測價值[J].武漢大學學報:醫(yī)學版,2024,45(5):582-588.

相似文獻/References:

[1]李 敏 姜 鋒 魏瀟琪 王小易 林燕清 鄭煒平.Kisspeptin對胰島β細胞的凋亡影響及作用機制研究[J].福建醫(yī)藥雜志,2020,42(01):125.
　LI Min,JIANG Feng,WEI Xiaoqi,et al.Study on the effect and mechanism of kisspeptin on apoptosis of islet β cells[J].FUJIAN MEDICAL JOURNAL,2020,42(03):125.
[2]林燕玲,葉靜,黃淑玲,等.血清VEGF、BDNF水平與老年糖尿病大鼠認知功能障礙相關性研究[J].福建醫(yī)藥雜志,2022,44(02):123.
　LIN Yanling,YE Jing,HUANG Shuling,et al.The correlation between serum levels of VEGF and BDNF and cognitive dysfunction in elderly diabetic rats[J].FUJIAN MEDICAL JOURNAL,2022,44(03):123.
[3]陳端英,何孫本,黃旭日,等.MicroRNA-16-5p和血管內(nèi)皮生長因子與糖尿病微血管病變的相關性研究[J].福建醫(yī)藥雜志,2024,46(03):9.[doi:10.20148/j.fmj.2024.03.003]
　CHEN Duanying,HE Sunben,HUANG Xuri,et al.Correlation between expression of serum MicroRNA-16-5p and vascular endothelial growth factor and diabetic microangiopathy[J].FUJIAN MEDICAL JOURNAL,2024,46(03):9.[doi:10.20148/j.fmj.2024.03.003]

備注/Memo

備注/Memo:
基金項目:福建省衛(wèi)健委青年科研課題項目(2021QNB010); 福建中醫(yī)藥大學康復技術省部共建協(xié)同創(chuàng)新中心(X2022011-協(xié)同)
通信作者:尹蓮花,Email:[email protected]
更新日期/Last Update: 2025-03-20